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   The usefulness of preventive chemotherapy was studied in transurethrally prostatectomized 
patients with no prior urinary tract infections. They were divided into two groups (A and B) 
randomized by the envelope method. 
   A was administered intravenously piperacillin (PIPC) 2 g once after surgery, and twice on the 
following day. B was similarly administered PIPC intravenously, followed by oral administration 
of  tosufloxacin tosilate (TFLX)  300  mg twice daily from the second to the fifth day. 
   Of the total of 135 cases, 104, 45 in A and 59 in B, conformed to the patient standards 
established for analysis. 
   Efficacy was assessed by the primary physician and also according to a unified standard in 
which the onset of a post-surgical infection and a bacteriuria of  104 or greater CFU/ml observed 
ten days after surgery were regarded as ineffective. 
   An intergroup statistically significant difference was not observed in the efficacy rate assessed 
by the primary physician. However, according to the unified standard assessment, B showed a 
significantly higher efficacy rate (88.1%) than A (62.2%). The administration of TFLX following 
PIPC was useful. 
   With an indwelling catheter, B exhibited a significantly greater efficacy rate when the retention 
period was four days or longer. The efficacy was greater in both groups if lavage was not per-
formed, and this effect was greater in A. Consequently, the administration of TFLX was consid-
ered more useful for long-term indwelling catheter cases. 
   Neither serious side effects, nor clinical test abnormalities were observed in this study. 
                                                (Acta Urol. Jpn. 39: 491-490,1993)
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とPIPC投与後に 一ユーキノロン剤 の一 つである
tosufloxacintosilate(以下TFLXと 略す)を4日
間継続投与する群(以 下B群 とする)の2群 間で予防
的化学療法の有用性を比較検討 し若干の知見をえたの
で報告する.
























































































Table2a.臨床 効 果(主 治医 判 定)





Table2b.臨床 効 果(統 一 判 定)






Table3.無 効 症 例 一 覧






前 立 腺 炎+精 巣 上体 炎1例P.aeruginosa(los) IPM/CS十FOMにて治癒
















































伴 う尿路感染症2例 の計6例 であったが,B群 では
38.0℃以」二の発熱を伴う腎孟腎炎が1例 のみであっ




















































中1例(1.3%)であ り,B群 で は78例中2例(2,6
%)で あった.そ の内訳は,A群 では投与中止した発






























































した.B群 はA群 と尉融 こPIPC静注の緩継続 して
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